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In many fields, researchers are interested in large and complex bi-
ological processes. Two important examples are gene expression and
DNAmethylation in genetics. One key problem is to identify aberrant
patterns of these processes and discover biologically distinct groups.
In this article we develop a model-based method for clustering such
data. The basis of our method involves the construction of a like-
lihood for any given partition of the subjects. We introduce cluster
specific latent indicators that, along with some standard assumptions,
impose a specific mixture distribution on each cluster. Estimation is
carried out using the EM algorithm. The methods extend naturally to
multiple data types of a similar nature, which leads to an integrated
analysis over multiple data platforms, resulting in higher discrimi-
nating power.
1. Introduction. Epigenetics refers to the study of heritable character-
istics not explained by changes in the DNA sequence. The most studied
epigenetic alteration is cytosine (one of the four bases of DNA) methyla-
tion, which involves the addition of a methyl group (a hydrocarbon group
occurring in many organic compounds) to the cytosine. Cytosine methyla-
tion plays a fundamental role in epigenetically controlling gene expression,
and studies have shown that aberrant DNA methylation patterning occurs
in inflammatory diseases, aging, and is a hallmark of cancer cells [Roden-
hiser and Mann (2006); and Figueroa et al. (2010)]. Figueroa et al. (2010)
performed the first large-scale DNA methylation profiling study in humans,
where they hypothesized that DNA methylation is not randomly distributed
in cancer but rather is organized into highly coordinated and well-defined
patterns, which reflect distinct biological subtypes. Similar observations had
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already been made for expression data [Golub et al. (1999); Armstrong et al.
(2002)]. Identifying such biological subtypes through abnormal patterns is
a very important task, as some of these malignancies are highly heteroge-
neous, presenting major challenges for accurate clinical classification, risk
stratification and targeted therapy. The discovery of aberrant patterns in
subjects can identify tumors or disease subtypes and lead to a better under-
standing of the underlying biological processes, which in turn can guide the
design of more specifically targeted therapies. Due to the biological inter-
action between methylation and expression, biologists hope to optimize the
amount of biological information about cancer malignancies by borrowing
strength across both platforms. As an example Figueroa et al. (2008) showed
that the integration of gene expression and epigenetic platforms could be
used to rescue genes that were biologically relevant but had been missed by
the individual analyses of either platform separately.
In this article we propose a model-based approach to clustering such high-
dimensional microarray data. In particular, we build finite mixture models
that guide the clustering. These types of models have been shown to be
a principled statistical approach to practical issues that can come up in
clustering [McLachlan and Basford (1988); Banfield and Raftery (1993);
Cheeseman and Stutz (1995); Fraley and Raftery (1998, 2002)]. The moti-
vating application is the cluster analysis of Figueroa et al. (2010), which
focused on patients with Acute Myeloid Leukemia (AML). Both methyla-
tion and expression data are available and we develop a clustering method
that can be applied to both data types separately. Furthermore, we extend
our methodology to facilitate an integrated cluster analysis of both data
platforms simultaneously. Although the methods are designed for these par-
ticular applications, we expect that they can be applied to other types of
microarray data, such as ChIP-chip data.
A lot of attention has been given to classification based on gene expres-
sion profiles and more recently based on methylation profiles. Siegmund,
Laird and Laird-Offringa (2004) give an overview and comparison of several
clustering methods on DNA methylation data. They point out that among
biologists, agglomerative hierarchical cluster analysis is popular. However,
they argue in favor of model-based clustering methods over nonparametric
approaches and propose a Bernoulli-lognormal model for the discovery of
novel disease subgroups. This model had previously been applied by Ibrahim,
Chen and Gray (2002) to identify differentially expressed genes and profiles
that predict known disease classes. More recently, Houseman et al. (2008)
proposed a Recursively Partitioned Mixture Model algorithm (RPMM) for
clustering methylation data using beta mixture models [Ji et al. (2005)].
They proposed a beta mixture on the subjects and the objective was to clus-
ter subjects based on posterior class membership probabilities. The RPMM
approach is a model-based version of the HOPACH clustering algorithm
developed in van der Laan and Pollard (2003).
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In high-dimensional data clustering is often performed on a smaller sub-
set of the variables. In fact, as pointed out in Tadesse, Sha and Vannucci
(2005), using all variables in high-dimensional clustering analysis has proven
to give misleading results. There is some literature on the problem of simul-
taneous clustering and variable selection [Friedman and Meulman (2003);
Tadesse, Sha and Vannucci (2005); Kim, Tadesse and Vannucci (2006)].
However, most statistical methods cluster the data only after a suitable
subset has been chosen. An example of such practice is McLachlan, Bean
and Peel (2002), where the selection of a subset involves choosing a signifi-
cance threshold for the covariates. That is also essentially what Houseman
et al. (2008) and Figueroa et al. (2010) did, but they selected a subset of
the most variable DNA fragments. In this paper we present an integrated
model-based hierarchical clustering algorithm that clusters samples based on
multiple data types on the most variable features. There is of course a clear
advantage of automated variable selection methods such as in Tadesse, Sha
and Vannucci (2005). However, the implementation of such methods seems
far from straightforward and due to the popularity of hierarchical algorithms
among biologists [Kettenring (2006) concluded that hierarchical clustering
was by far the most widely used form of clustering in the scientific litera-
ture], there is a clear benefit in having a simple hierarchical algorithm that
can handle multiple data types.
The article is organized as follows. In Section 2 we describe the features of
the motivating data set. In Section 3 we construct the model as a mixture of
Gaussian densities, which leads to a specific mixture likelihood that serves
as an objective function for clustering. We also introduce individual specific
parameters to account for subject to subject variability within clusters (i.e.,
the array effect). In Section 4 we present two model-based clustering algo-
rithms. The first algorithm is a hierarchical clustering algorithm that can
be used to find a good candidate partition. The second clustering algorithm
is an iterative algorithm that is designed to improve upon any initial parti-
tion. The likelihood model can be applied to classification of new subjects
and in Section 5 we describe a discriminant rule for this purpose. In Sec-
tion 6 we extend the model to account for multiple data platforms and in
Sections 7 and 8 we apply the methods to real data sets, which involve both
methylation and expression data. We conclude the article with a discussion
in Section 9.
2. Motivating data. The Erasmus data were obtained from AML sam-
ples collected at Erasmus University Medical Center (Rotterdam) between
1990 and 2008 and involve DNA methylation and expression profiles of
344 patient specimens. For each specimen it was confirmed that >90% of
the cells were blasts (leukemic cells). Description of the sample processing
can be found in Valk et al. (2004) and data sets are available in GEO,
http://www.ncbi.nlm.nih.gov/geo/, with accession numbers GSE18700
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for the methylation data and GSE6891 for the expression data. The gene ex-
pression profiles of the AML samples were determined using oligonucleotide
microarrays (Affymetrix U133Plus2.0 GeneChips) and were normalized us-
ing the rma normalization method of Irizarry et al. (2003). The processed
data involved 54,675 probe sets and demonstrated a right skewed distribu-
tion of the expression profiles for each subject; see Supplementary Figure
1 in the supplemental article [Kormaksson et al. (2012)]. The methylation
profiles of the AML samples were determined using high density oligonu-
cleotide genomic HELP arrays from NimbleGen Systems that cover 25,626
probe sets at gene promoters, as well as at imprinted genes. Briefly, genomic
DNA is isolated and digested by the enzymes HpaII and MspI, separately.
While HpaII is only able to cut the DNA at its unmethylated recognition
motif (genomic sequence 5′-CCGG-3′), MspI cuts the DNA at any HpaII
site whether methylated or unmethylated. Following PCR, the HpaII and
MspI digestion products are labeled with different fluorophores and then co-
hybridized on the microarray. This results in two average signal intensities
that measure the relative abundances (in a population of cells) of MspI and
HpaII at each probe set. The data are preprocessed and normalized using
the analytical pipeline of Thompson et al. (2008) and the final quantity of
interest is log(HpaII/MspI). Note that although theoretically HpaII should
always be less than MspI, complex technical aspects that arise during the
preparation and hybridization of these samples may result in an enrichment
of the HpaII signal over that of MspI. Therefore, the log-ratio does not have
a one-to-one correspondence with percent methylation at a given probe set
but rather provides a relative methylation value that correlates with actual
percentage value (see lower left panel of Figure 1).
In what follows, notation will be based on the HELP methylation data.
However, if we abstract away from this particular application, the terminol-
ogy can be adapted to other microarray data such as gene expression. Let yij
denote the continuous response log(HpaIIij/MspIij) for subject i= 1, . . . , n,
and probe set j = 1, . . . ,G. Lower values of yij indicate that probe set j has
high levels of methylation (in a population of cells) for subject i, whereas
higher values indicate low levels of methylation. In the upper panel of Fig-
ure 1 we see bimodal histograms of the methylation profiles for two pa-
tients in the AML data set along with two component Gaussian mixture
fits. In Supplementary Figure 2 of the supplemental article [Kormaksson
et al. (2012)] we see density profiles for all 344 samples stratified by clus-
ters. There is a large microarray effect in the methylation data, but we
observe that all profiles are either skewed or exhibit a bimodal behavior.
The lower left panel of Figure 1 shows how the HELP assay correlates with
methylation percentages obtained using the more accurate, but much more
expensive, quantitative single locus DNA methylation validation MASS Ar-
ray [see Figueroa et al. (2010)]. It is clear that the HELP values are forming
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Fig. 1. Upper panel: A histogram of the log signal ratio, log(HpaII/MspI), for patients
number 41 and 42 in the Erasmus data set, along with two component Gaussian mix-
ture fits. Lower panel: Left graph shows HELP methylation values plotted against more
accurate MASS array methylation percentages. Right graph shows that the posterior prob-
abilities from a two component Gaussian mixture classifies probe sets well into low and
high methylation.
two clusters of relatively low or high methylation levels with some noise
in the percentage range [20%,80%]. This apparent dichotomization inspires
modeling each individual profile, yi = (yi1, . . . , yiG)
′, with a two component
mixture distribution and normality is assumed for each component due to
its flexibility and ease of implementation. We know of no biological mecha-
nism that would imply normality, however, the assumption gives consistent
and reasonable fits of the individual methylation profiles (see upper panel
of Figure 1).
3. Model specification. By dichotomizing the methylation process we
can cluster the probe sets into high or low methylation for each patient i
by applying a two component Gaussian mixture model. Let C denote the
true partition of the subject set, [n] = {1, . . . , n}. We assume that on any
given probe set j, all subjects sharing a cluster c ∈ C have the same relative
methylation status (high or low), and introduce for each cluster c a single
latent indicator vector, wc = (wc1, . . . ,wcG)
′, with
wcj =
{
1, if j has high methylation for all subjects in cluster c,
0, if j has low methylation for all subjects in cluster c.
(1)
It is well known that methylation does exhibit biological variability from
individual to individual. However, it is biologically reasonable to expect
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consistency in relative methylation patterns for patients that share the same
disease subtype. Define θi = (µ1i, σ
2
1i, µ2i, σ
2
2i)
′ and assume that the observed
data, y = (y′1, . . . ,y
′
n)
′, given the unobserved methylation indicators, w =
(w′1, . . . ,w
′
K)
′ (K being the number of clusters), arise from the following
density:
f(y|w,θ) =
∏
c∈C
∏
i∈c
f(yi|wc,θi),(2)
with
f(yi|wc,θi) =
G∏
j=1
φ(yij|µ1i, σ
2
1i)
wcjφ(yij |µ2i, σ
2
2i)
1−wcj ,(3)
where φ denotes the normal density and θ = (θ′1, . . . ,θ
′
n)
′. We refer to the
density in (2) as the classification likelihood of the observed data [Scott and
Symons (1971); Symons (1981); Banfield and Raftery (1993)] and assume
µ1i < µ2i for all i. We interpret θi as the individual specific means and
variances of the high and low methylation probe sets, respectively. Note that
this setup is different from the usual model-based clustering setup where we
have cluster specific parameters only. However, due to array effects, it is
reasonable and in fact necessary to require different parameters for different
subjects. In the upper panel of Figure 1 we see histograms and fits for
two patients that both have chromosomal inversions at chromosome 16,
inv(16) (inversions refer to when genetic material from a chromosome breaks
apart and then, during the repair process, it is re-inserted back but the
genetic sequence is inverted from its original sense). These two patients
cluster together under various clustering algorithms, including the model-
based algorithm presented below. However, the two distributions are clearly
not equal.
We put a Bernoulli prior on the latent methylation indicators in (1):
f(w) =
∏
c∈C
G∏
j=1
π
wcj
1c π
1−wcj
0c , π0c + π1c = 1,(4)
where π1c and π0c denote the proportions of probe sets that have high and
low methylation, respectively, in cluster c. From (2) and (4) it is clear that
the complete data density is
f(y,w) =
∏
c∈C
G∏
j=1
(
π1c
∏
i∈c
φ(yij|µ1i, σ
2
1i)
)wcj(
π0c
∏
i∈c
φ(yij|µ2i, σ
2
2i)
)1−wcj
,(5)
and if we integrate out the latent variable w, we arrive at the marginal
likelihood
LC(Ψ) =
∏
c∈C
G∏
j=1
(
π1c
∏
i∈c
φ(yij|µ1i, σ
2
1i) + π0c
∏
i∈c
φ(yij|µ2i, σ
2
2i)
)
,(6)
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where Ψ= {(π1c)c∈C , (µ1i, σ
2
1i, µ2i, σ
2
2i)i} denotes the set of parameters. This
likelihood can be used as an objective function for determining the goodness
of different partitions and the maximization of (6) is carried out with the EM
algorithm of Dempster, Laird and Rubin (1977). Note that LC can be written
as a product,
∏
c∈C Lc, where Lc denotes the likelihood contribution of clus-
ter c. Thus, maximizing LC can be achieved by maximizing Lc independently
for all c ∈ C. Details of the maximization algorithm are provided in Supple-
mentary Appendix B of the supplemental article [Kormaksson et al. (2012)].
Remark 1. The premise of the clustering algorithm presented in Sec-
tion 4 is to cluster subjects together that have similar methylation patterns.
Similarities across the genome in the posterior probabilities of high/low
methylation guide which subjects are clustered together and, thus, if the
posterior probability predictions reflect the data well, the clustering algo-
rithm should perform well. In the lower right panel of Figure 1 we see that
the posterior probabilities of high methylation fit very well with the actual
percentage values.
Remark 2. When we allow for unequal variances σ21i 6= σ
2
2i, the likeli-
hood in (6) is unbounded and does not have a global maximum. This can be
seen by setting one of the means equal to one of the data points, say, µ1i =
yij , for some i, j. Then the likelihood approaches infinity as σ
2
1i → 0+. How-
ever, McLachlan and Peel (2000), using the results of Kiefer (1978), point out
that, even though the likelihood is unbounded, there still exists a consistent
and asymptotically efficient local maximizer in the interior of the parameter
space. They recommend running the EM algorithm from several different
starting values, dismissing any spurious solution (on its way to infinity),
and picking the parameter values that lead to the largest likelihood value.
Remark 3. Note that the likelihood in (6) is identifiable except for the
standard and unavoidable label switching problem in finite mixture models
[see, e.g., McLachlan and Peel (2000)]. Furthermore, there exists a sequence
of consistent local maximizers, as G→∞. This becomes more evident if
one recognizes that the expression for a single cluster c can be written as
a multivariate normal mixture
Lc =
G∏
j=1
(π1cφ(ycj |µ1c,Σ1c) + π0cφ(ycj |µ2c,Σ2c)),
where ycj = (y1j , . . . , yncj)
′, µkc = (µk1, . . . , µknc)
′ and Σkc = diag(σ
2
ki)
nc
i=1,
k = 1,2 (assuming for convenience that i = 1, . . . , nc are the members of
cluster c). Standard theory thus applies [see McLachlan and Peel (2000)].
Remark 4. The correlation structure of high-dimensional microarray
data is complicated and hard to model. Thus, we assume independence
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across variables in the likelihood (6) even though it may not be the ab-
solutely correct model. However, we can view (6) as a composite likelihood
[see Lindsay (1988)] which yields consistent parameter estimates but with
a potential loss of efficiency. The correlations observed in microarray data
are usually mild and involve only a few and relatively small groups of genes
that have moderate or high within-group correlations. In Supplementary
Appendix A of the supplemental article [Kormaksson et al. (2012)] we per-
form a simulation study to get a sense of how robust our algorithm is to this
independence assumption. The results indicate that with a sparse overall
correlation structure in which genes tend to group into many small clusters
with moderate to high within-group correlations, our algorithm is not af-
fected by assuming independence across variables. However, there is some
indication that with larger groups of genes with very extreme within-group
correlations the algorithm will break down. In microarray data such extreme
correlation structures are not to be expected on a global scale and, therefore,
we believe that the independence assumption is quite reasonable.
4. Model-based clustering. Our clustering criterion involves finding the
partition that gives the highest maximized likelihood LC as given in (6).
This provides us with a model selector, as we can compare the maximized
likelihoods of any two candidate partitions. In theory we would like to maxi-
mize LC with respect to all possible partitions of [n] and simply pick the one
resulting in the highest likelihood. However, as this is impossible for even
moderately large n, we propose two clustering algorithms. In Section 4.1
we propose a simple hierarchical clustering algorithm, and in Section 4.2 we
propose an iterative algorithm that is designed to improve upon any initial
partition.
4.1. Hierarchical clustering algorithm. In this subsection we describe
a simple hierarchical algorithm that attempts to find the partition that max-
imizes LC as given in (6). Heard, Holmes and Stephens (2006) used a similar
approach, but they constructed a hierarchical Bayesian clustering algorithm
that seeks the clustering leading to the maximum marginal posterior prob-
ability. The algorithm can be summarized in the following steps:
1. We start with the partition where each subject represents its own clus-
ter, C1 = {{1}, . . . ,{n}}, and calculate the maximized likelihood, LC1 . Note
that this likelihood can be written as a product LC1 =
∏
iL{i} and, thus, the
first step involves maximizing L{i} for each i= 1, . . . , n. This is achieved by
fitting a two-component Gaussian mixture to each of the n individual pro-
files. As mentioned in Remark 2, each fit can be obtained by using the EM
algorithm starting from several different initial values and finding a local
maximum. It is important that the user verifies these initial individual fits
before proceeding with the hierarchical algorithm. For example, by going
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through the 344 methylation profile fits of the Erasmus data, one by one,
we observe pleasing fits. The upper panel of Figure 1 gives examples of two
such profile fits.
2. Next we merge the two subjects that leads to the highest value of LC
and denote the maximized likelihood value by LC2 . Note that there are
(
n
2
)
many ways of merging two subjects at this step. However, since we already
obtained fits for L{i}, i = 1, . . . , n, at Step 1, we only need to maximize
L{i,i′}, for all pairs (i, i
′) and find the pair that maximizes
ℓC2 = ℓC1 − (ℓ{i} + ℓ{i′}) + ℓ{i,i′},
where ℓ denotes the loglikelihood. Even though we are applying several EM
algorithms, the complexity of each algorithm is low since it only involves
two subjects at a time.
3. We continue merging clusters under this maximum likelihood criteria,
at each step making note of the maximized likelihood, until we are left with
one cluster containing all n subjects, Cn = [n]. Among the n partitions that
are obtained, we pick the partition that has the highest value of LC . Note
that the likelihood value may either increase or decrease at each step. This
provides us with a method that automatically determines the number of
clusters.
It is our experience that the individual parameter estimates (µ1i, σ
2
1i, µ2i, σ
2
2i)i
do not change much at each merging step of the hierarchical algorithm. Thus,
if the initial estimates provide good fits for all the individual profiles, the
algorithm can be expected to perform well. Furthermore, by using the indi-
vidual parameter estimates at a previous merging step as initial values at
the next step, each EM algorithm converges very quickly, which is essen-
tial since the total number of EM algorithms that are conducted is of the
order O(n2). For the data sets that we consider in this article, the hierar-
chical algorithm takes anywhere from a couple of minutes to run, for the
smallest data set in Section 8.1 (n = 14), up to a couple of hours for the
Erasmus high-dimensional data set of Section 7.1 (n= 344), using a regular
laptop. However, it should be noted that our R code is neither optimized
nor precompiled to a lower level programming language at this stage.
4.2. Iterative clustering algorithm. The hierarchical algorithm results in
a partition that serves as a good initial candidate for the true partition. In
this subsection we present an iterative algorithm that is designed to improve
upon any initial partition. We introduce cluster membership indicators for
the subjects in order to develop an EM algorithm for clustering subjects
under the assumption of a fixed number of clusters. Define for each subject
i= 1, . . . , n and cluster c ∈ C
Xic =
{
1, if subject i is in cluster c,
0, otherwise,
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and letXi = (Xic)c∈C . AssumeX1, . . . ,Xn are i.i.d. Multinom{1,p= (pc)c∈C},
so the density of X= (X′1, . . . ,X
′
n)
′ is
f(X) =
n∏
i=1
∏
c∈C
pXicc ,
∑
c∈C
pc = 1.(7)
These cluster membership indicators fully define the partition C and we note
that the classification likelihood in (2) can be written as
f(y|X) =
∏
c∈C
n∏
i=1
f(yi|wc,θi)
Xic .(8)
Multiplying (7) and (8) together and integrating out X, we arrive at the
marginal likelihood
f(y;Ψ) =
n∏
i=1
∑
c∈C
pcf(yi|wc,θi),(9)
where Ψ= {(pc)c∈C , (wc)c∈C ,θi = (µ1i, σ
2
1i, µ2i, σ
2
2i)i} involves both the con-
tinuous parameters and the discrete indicators, w, which we now assume are
fixed. We make this assumption because if w is random as in (4), the joint
posterior distribution of (w,X) is highly intractable and an EM algorithm
based on (8) would be problematic.
The likelihood in (9) is that of a finite mixture model and can be max-
imized using the EM algorithm. We detail the maximization procedure in
Supplementary Appendix B of the supplemental article [Kormaksson et al.
(2012)]. In short, letX(0) denote the clustering labels corresponding to a can-
didate partition. Using X(0) as an initial partition, we run an EM algorithm
that converges to a local maximum of (9). Once the mixture model has been
fitted, a probabilistic clustering of the subjects can be obtained through
the fitted posterior expectations of cluster membership for the subjects,
(E[Xic|y])i,c [see McLachlan and Peel (2000)]. Essentially, a subject will be
assigned to the cluster to which it has the highest estimated posterior proba-
bility of belonging. We have found empirically that the derived partition not
only results in a higher value of (9) but also in the objective likelihood (6),
but we do not have a theoretical justification for this. A good clustering strat-
egy is to come up with a few candidate partitions, with varying numbers of
clusters, and run the EM algorithm using these partitions as initial parti-
tions. Each resulting partition will be a local maximum of (9), but we choose
the partition with the highest value of the original objective function (6).
Good initial partitions can be found by running the hierarchical algorithm
of Section 4.1 or applying one of the more standard clustering algorithms.
5. Classification. The construction of a likelihood for any given partition
of the subjects also provides a powerful tool for classification. Assume we
have methylation data on n subjects and we know which class each subject
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belongs to, that is, we know the true C. A by-product of maximizing the
likelihood in (6) with the EM algorithm [detailed in Supplementary Ap-
pendix B of the supplemental article, Kormaksson et al. (2012)] is posterior
predictions of the latent indicators, (wˆc)c∈C , which we round to either 0 or 1.
Given these estimated methylation indicators, the conditional likelihood of
a new observation (yij)j , on the assumption that i ∈ c, is given by
Lc(θi) =
G∏
j=1
φ(yij|µ1i, σ
2
1i)
wˆcjφ(yij|µ2i, σ
2
2i)
1−wˆcj .(10)
The discriminant likelihood, Lc, is maximized with respect to the individual
specific parameters at
µˆ1i =
∑
j wˆcjyij∑
j wˆcj
, σˆ21i =
∑
j wˆcj(yij − µˆ1i)
2∑
j wˆcj
,
µˆ2i =
∑
j(1− wˆcj)yij∑
j(1− wˆcj)
, σˆ22i =
∑
j(1− wˆcj)(yij − µˆ2i)
2∑
j(1− wˆcj)
.
By substituting these estimates into (10) we arrive at the following discrim-
inant rule:
i ∈ c if Lc(θˆi(wˆc))>Lc′(θˆi(wˆc′)) for all c
′ 6= c.(11)
6. Extension to multiple platforms. In this section we discuss how to
extend the methods of this paper to account for multiple data types as long
as each data type can reasonably be modeled by the model described in
Section 3. For subject i= 1, . . . , n let yijk denote the signal response of the
jth variable, j = 1, . . . ,Gk, on platform k = 1, . . . ,m. As before, we let C
denote the true partition of the n subjects. We assume subjects in a given
cluster c ∈ C have identical activity (methylation, expression, etc.) profiles on
each platform k = 1, . . . ,m independently and define a cluster and platform
specific indicator for each variable
wcjk =
{
1, if variable j on platform k is active in cluster c,
0, if variable j on platform k is inactive in cluster c.
Define wc = (wcjk)j,k and let yi = (yijk)j,k denote the vector of observed ac-
tivity profiles of subject i across platforms. Let θi = (µ1ik, σ
2
1ik, µ2ik, σ
2
2ik)
m
k=1
denote the subject specific mixture parameters. We assume that the ob-
served data, y = (yT1 , . . . ,y
T
n )
T , given the unobserved activity indicators,
w= (wc)c∈C , arise from the following density:
f(y|w,θ) =
∏
c∈C
∏
i∈c
f(yi|wc,θi),
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where the conditional density of yi, on the assumption that i ∈ c, is given
by
f(yi|wc,θi) =
m∏
k=1
Gk∏
j=1
φ(yijk|µ1ik, σ
2
1ik)
wcjkφ(yijk|µ2ik, σ
2
2ik)
1−wcjk .
We can either assume that the activity indicators for cluster c are fixed
as in subection 4.2, or independent Bernoullis, both across platforms and
variables,
f(wc) =
m∏
k=1
Gk∏
j=1
π
wcjk
1ck π
1−wcjk
0ck , π1ck + π0ck = 1,
where π1ck represents the proportions of variables on platform k that are
active in cluster c. The likelihood in this integrated framework is identical
to the one given in (6), except we now have an additional product across
platforms k. The methods presented in Sections 4 and 5 thus extend to
multiple platforms in a straightforward manner.
7. Identifying subtypes of AML. Figueroa et al. (2010) performed the
first large-scale DNA methylation profiling study in humans using the Eras-
mus data described in Section 2. They clustered patients using hierarchical
correlation based clustering on a subset of the most variable probe sets.
Using unsupervised clustering, they were able to classify the patients into
known and well-characterized subtypes as well as discover novel clusters. In
Section 7.1 we report our clustering results on the data and compare to those
of Figueroa et al. (2010). We ran a cluster analysis on both methylation and
expression data separately as well as an integrative cluster analysis on both
platforms simultaneously. In Section 7.2 we present results from a discrim-
inant analysis study in which we classified an independent validation data
set using the methods of Section 5.
7.1. Clustering results. Figueroa et al. (2010) hierarchically clustered the
n = 344 patients (methylation profiles only) on a subset of the 3745 most
variable probe sets, using 1-correlation distance and Ward’s agglomeration
method. These were probe sets that exceeded a standard deviation threshold
of 1. We ran the hierarchical algorithm of Section 4.1 on the same subset
to obtain an initial partition. Among the 344 candidate partitions, obtained
at each merging step, the loglikelihood was maximized at K = 17 clusters,
but to avoid singletons we chose a partition with K = 16, the same number
of clusters Figueroa et al. (2010) chose. We then applied the iterative algo-
rithm of Section 4.2 in an attempt to improve upon the initial partition. We
denote the resulting partition “M” (Methylation). We repeated this process
separately for the expression data using the 3370 most variable probe sets, or
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those that exceeded a standard deviation threshold of 0.5. This resulted in
a partition “E” (Expression) with K = 17 clusters. Finally, we repeated this
process jointly on the 3745 and 3370 probe sets from the methylation and
expression data, respectively, resulting in the partition “ME” with K = 14
clusters.
Figueroa et al. (2010) identified 3 robust and well-characterized biological
clusters and 8 clusters that were associated with specific genetic or epige-
netic lesions. Five clusters seemed to share no known biological features. The
three robust clusters corresponded to cases with inversions on chromosome
16, inv(16), and translocations between chromosomes 15 and 17, t(15; 17),
and chromosomes 8 and 21, t(8; 21) (translocations refer to when genetic
material from two different chromosomes breaks apart and when being re-
paired, the material from one chromosome is incorrectly attached to the
other chromosome instead and vice versa). The World Health Organization
has identified these subtypes of AML as indicative of favorable clinical prog-
nosis [see, e.g., Figueroa et al. (2010)]. The remaining 8 clusters included
patients with CEBPA double mutations (two different abnormal changes in
the genetic code of the CEBPA gene), CEBPA mutations irrespective of type
of mutation, silenced CEBPA (abnormal loss of expression of CEBPA which
is not due to mutations in the genetic code), one cluster enriched for 11q23
abnormalities (any type of change in the genetic code that affects position 23
of the long arm of chromosome 11) and FAB M5 morphology (specific shape
and general aspect of the leukemic cell as defined by the French American
British classification system for Acute Leukemias), and four clusters with
NPM1 mutations (mutations in the genetic code of the NPM1 gene). A de-
tailed sensitivity and specificity analysis of 6 of the above 11 clusters [sam-
ple sizes in brackets], inv(16) [n1 = 28], t(15; 17) [n2 = 10], t(8; 21) [n3 = 24],
CEBPA double mutations [n4 = 24], CEBPA silenced AMLs [n5 = 8], and
11q23 + FAB M5 [n6 = 7], is given in Table 1 for the different clustering
results. We include the correlation based clustering result (COR) on the
methylation data to compare with “M.” The remaining five of the 11 bio-
logical clusters (CEBPA mutations irrespective of type of mutation and the
four NPM1 mutation clusters) had sensitivity or specificity below 0.5 for all
four clustering results and were thus excluded from the table. We can see
that the model-based approach, “M,” is doing better than the correlation
based method, “COR,” for the most part. Aside for sensitivity of t(8; 21)
(1 less false negative) and specificity of inv(16) (1 less false positive), the
model-based approach has as good or better sensitivity and specificity. The
most striking differences are in the numbers of false negatives of CEBPA
dm and false positives of t(8; 21) where “M” is doing better. Note also that
aside for the sensitivity of 11q23 + FAB M5 and specificity of t(8; 21), the
integrated analysis “ME” always does better than the analyses “M” and
“E” separately, with perfect sensitivity and specificity for many of the clus-
ters. Most notably, the integrative analysis is able to perfectly classify the
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Table 1
The sensitivity and specificity of the clustering results
Subtype COR M E ME
Sensitivity (# of false negatives in parentheses)
inv(16) [n1 = 28] 0.929 (2) 0.964 (1) 0.857 (4) 0.964 (1)
t(15; 17) [n2 = 10] 0.800 (2) 0.800 (2) 1.000 (0) 1.000 (0)
t(8; 21) [n3 = 24] 0.917 (2) 0.875 (3) 0.917 (2) 0.958 (1)
CEBPA dm [n4 = 24] 0.792 (5) 0.917 (2) 0.75 (6) 1.000 (0)
CEBPA Sil [n5 = 8] 0.625 (3) 0.875 (1) 1.000 (0) 1.000 (0)
11q23 +FAB M5 [n6 = 7] 0.857 (1) 0.857 (1) 0.714 (2) 0.714 (2)
Specificity (# of false positives in parentheses)
inv(16) [n− n1 = 316] 1.000 (0) 0.997 (1) 0.997 (1) 1.000 (0)
t(15; 17) [n− n2 = 334] 1.000 (0) 1.000 (0) 1.000 (0) 1.000 (0)
t(8; 21) [n− n3 = 320] 0.972 (9) 0.994 (2) 1.000 (0) 0.991 (3)
CEBPA dm [n− n4 = 320] 0.988 (4) 0.988 (4) 0.991 (3) 1.000 (0)
CEBPA Sil [n− n5 = 336] 1.000 (1) 0.997 (1) 0.985 (5) 0.997 (1)
11q23 +FAB M5 [n− n6 = 337] 0.991 (3) 0.991 (3) 0.991 (3) 0.994 (2)
CEBPA double mutants even though both “M” and “E” have quite a few
false positives and false negatives. This demonstrates the increased power to
identify clusters by sharing information across multiple platforms. As a side
product from our clustering algorithm, we obtain posterior probabilities of
high methylation/expression, E[wcj |y], which can be used to order genes in
heatmaps to discover subtype specific methylation/expression patterns. In
Figure 2 we see heatmaps of the two data sets used for the integrative cluster-
ing, “ME,” after rows have been ordered by increasing posterior probabilities
(one cluster at a time). Such heatmaps are useful for graphically displaying
the distinct methylation/expression patterns that characterize the different
subtypes of cancer.
7.2. Classification results. A second cohort of patients with AML was
available with which we could test the performance of the classification
method of Section 5. This second cohort of n= 383 cases consisted of sam-
ples, obtained from patients enrolled in a clinical trial from the Eastern Co-
operative Oncology Group (ECOG) (Data are available at http://www.ncbi.
nlm.nih.gov/geo/, accession number pending). These patients were similar
in characteristics to the Erasmus cohort, with only one exception, all pa-
tients were younger than 60 years of age. Samples were processed in the
same way as the Erasmus cohort, and their methylation was used to blindly
predict their molecular diagnosis. Using the 3745 most variable probe sets
and the clustering result “M” of the previous section, we fit the model (6)
on the Erasmus cohort with the EM algorithm. By using the posterior pre-
dictions of the methylation indicators, we applied the discriminant rule (11)
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Fig. 2. Heatmaps of the methylation and gene expression values for the 6 well-charac-
terized clusters obtained from the integrative clustering (“ME”). Columns correspond to
patient samples and rows correspond to genes. On the left heatmap “yellow,” “gray” and
“blue” represent low, intermediate and high methylation, respectively. On the right heatmap
“green,” “black” and “red” represent low, intermediate and high expression, respectively.
Rows are ordered by increasing posterior probabilities of high methylation/expression,
E[wcj |y], first for inv(16), then for t(8; 21), t(15; 17), CEBPdm, CEBPsil, and finally
for 11q23+M5. Rows with equal probabilities for all 6 clusters (either equal to 1 or 0) are
excluded to emphasize differences.
on each patient in the ECOG data set. Since CEBPA and NPM1 mutation
status have not yet been made available for this cohort, only the perfor-
mance for the prediction of the inv(16), t(8; 21), CEBPA silenced, t(15; 17)
and 11q23 +FAB M5 clusters could be tested. Inv(16) cases were predicted
with 100% sensitivity and specificity. The predicted t(8; 21) cluster con-
tained 100% of cases positive for this abnormality, and only one t(8; 21)
case was misclassified to another cluster. Two cases, which had previously
been unrecognized as CEBPA silenced AMLs, were predicted by the classi-
fication method. One of them was later confirmed to indeed correspond to
this molecular subtype by an alternative methylation measurement method.
Similarly, one case was believed to have been misclassified as t(15; 17) since
there were no molecular data confirming the presence of the PML-RARA
gene fusion (the abnormal combination of the PML and RARA genes) re-
sulting from this translocation. However, it was later confirmed that both
the morphology and the immune diagnosis corresponded to that of an acute
promyelocytic leukemia with t(15; 17). Finally, the 11q23 + FAB M5 clus-
ter included 9 of the 14 patients in the cohort that met these two criteria.
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Table 2
The sensitivity and specificity of the classification result.
False negatives and false positives are in parentheses
Subtype Sensitivity Specificity
inv(16) [n= 32] 1.000 (0) 1.000 (0)
t(15; 17) [n= 1] 1.000 (0) 1.000 (0)
t(8; 21) [n= 28] 0.964 (1) 1.000 (0)
CEBPA Sil [n= 1] 1.000 (0) 0.997 (1)
11q23 +FAB M5 [n= 14] 0.643 (5) 0.986 (5)
There were also 5 false positives, 3 of them were M5 cases but did not have
11q23 abnormalities, 1 of them harbored the 11q23 abnormality but corre-
sponded to an M1, and the remaining case corresponded to an M4 case with
a hyperdiploid karyotype. A summary of these results is provided in Table 2.
8. Other applications. The clustering method presented in this paper
is not restricted to the microarray platforms that the AML samples were
processed on. In this section we demonstrate the versatility of our method
by applying it to other microarray platforms and show that our algorithm
does well in clustering subjects. We also provide a comparison with other
existing methods for clustering microarray data.
8.1. Expression in endometrial cancer. In this subsection we analyze the
microarray expression data set in Tadesse, Sha and Vannucci (2005). En-
dometrioid endometrial adenocarcinoma is a gynecologic malignancy typ-
ically occurring in postmenopausal women. Identifying distinct subtypes
based on common patterns of gene expression is an important problem, as
different clinicopathologic groups may respond differently to therapy. Such
subclassification may lead to discoveries of important biomarkers that could
become targets for therapeutic intervention and improved diagnosis. High
density microarrays (Affymetrix Hu6800 chips) were used to study expres-
sion of 4 normal and 10 endometrioid adenocarcinomas on 7070 probe sets.
Probe sets with at least one unreliable reading (limits of reliable detection
were set to 20 and 16,000) were removed from the analysis, which resulted in
G = 762 variables. Finally, the data were log-transformed, however, unlike
Tadesse, Sha and Vannucci (2005), we chose not to rescale the variables by
their range. More details about the data set can be found in Tadesse, Ibrahim
and Mutter (2003) and is publicly available at http://endometrium.org.
We hierarchically clustered the samples using the 300 most variable probe
sets and plotted the results in Figure 3. We successfully separated the four
normal tissues from the endometrial cancer tissues and the log-likelihood
plot suggests that K = 2. The dendrogram consistently separated the nor-
mals and the cancer into two branches for different variance thresholds.
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Fig. 3. Left panel: Cluster dendrogram for the 2 normal proliferative (“P”) endometria,
2 normal secretory (“S”) endometria, and 10 endometrioid adenocarcinomas (“T”). Right
panel: Plot of the number of clusters against log-likelihood.
However, if we lowered the threshold too much, the loglikelihood was maxi-
mized at K = 1. This makes sense, as including many low variability probe
sets might mask the true clustering structure. For comparison, Tadesse, Sha
and Vannucci (2005) concluded that K = 3 and commented that there could
possibly be 2 subtypes of endometrial cancer. However, to the best of our
knowledge, this subclustering has not been verified. They also reported clus-
tering results using the COSA algorithm of Friedman and Meulman (2003),
which, like our analysis, seemed more suggestive of K = 2.
8.2. Methylation in normal tissues. Houseman et al. (2008) used the
RPMM algorithm to cluster a methylation data set consisting of 217 nor-
mal tissues and compared the performance to that of the HOPACH al-
gorithm of van der Laan and Pollard (2003). The RPMM analysis was
discussed in more detail in Christensen et al. (2009) and the data made
publicly available at the GEO depository with accession number GSE19434
(http://www.ncbi.nlm.nih.gov/geo/). Briefly, DNA was extracted from
the tissues, modified with sodium bisulfite, and processed on the Illumina
GoldenGate methylation platform. Average fluorescence for methylated (M )
and unmethylated (U ) alleles were derived from raw data at 1505 loci. How-
ever, in this study 1413 loci passed the quality assurance procedures. A total
of 11 tissue types were available, bladder (n= 5), adult blood (n= 30), in-
fant blood (n= 55), brain (n= 12), cervix (n= 3), head and neck (n= 11),
kidney (n= 6), lung (n= 53), placenta (n= 19), pleura (n= 18) and small
intestine (n = 5). Houseman et al. (2008) constructed an average “beta”
value from raw data, which they claimed was very close to the quantity
M/(M + U) ∈ (0,1), rendering a beta distributional assumption (assum-
18 KORMAKSSON, BOOTH, FIGUEROA AND MELNICK
Table 3
Cross-classification of our clustering result (K = 8) and tissue type. By merging the top
two clusters, and clusters 3 and 4, we obtain the clustering corresponding to K = 6
Class Blad Bl Br Cerv Inf bl HN Kid Lung Plac Pleu Sm int
1 5 2 1 53 18 4
2 1
3 6
4 10 1
5 30
6 12
7 55
8 19
ing M and U follow a gamma distribution) with class and locus specific
parameters. We, however, chose to work with the quantity log(M/U), which
fits better with our two component mixture distributional assumption. In or-
der to get a direct comparison with RPMM and HOPACH, we used all 1413
loci. In Supplementary Figure 3 of the supplemental article [Kormaksson
et al. (2012)] we see a plot of cluster number versus loglikelihood, which is
maximized at K = 6 clusters. However, given the relatively small difference
between the loglikelihood values at K = 6, K = 7, and K = 8, one could ar-
gue that all three clustering results are worthy of consideration. The clusters
are cross-classified with tissue type in Table 3.
If we compare these results with those obtained with the RPMM algo-
rithm, our result favors few and concise clusters, whereas RPMM is in-
dicative of a total of 23 subclasses of tissues. The HOPACH clustering
algorithm was suggestive of K = 9 clusters, with 3 of those clusters rep-
resenting placenta singletons separated from the main placenta cluster. We
present a cross-classification table for both RPMM and HOPACH in Supple-
mentary Table 3 of the supplemental article [Kormaksson et al. (2012)] for
comparison [borrowed from Houseman et al. (2008)]. Our method perfectly
classifies blood, brain, infant blood, kidney and placenta. For comparison,
after bundling subclusters together, RPMM classifies blood and infant blood
perfectly, and HOPACH classifies infant blood and placenta perfectly. All
three methods have problems distinguishing between bladder, cervical, lung,
pleural and small intestine tissues. Overall, our approach seems to outper-
form HOPACH, and although Houseman et al. (2008) have demonstrated
that a few of their tissue-specific subclusters (obtained by RPMM) have ver-
ifiable meanings, such as through age difference, it seems that without a fur-
ther justification of such finer substructure in the data our clustering result
is more desirable. As a side note, under the assumption of Houseman et al.
(2008) thatM and U follow a gamma distribution, it is clear that log(M/U)
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will not be a mixture of two Gaussian distributions. The favorable cluster-
ing result for this data set suggests that the normality assumption on each
mixture component provides a robust and flexible modeling distribution.
9. Discussion. We have proposed a model-based method for clustering
microarray data. The methods have been demonstrated to work well on ex-
pression data and methylation data separately. An integrated cluster anal-
ysis has further shown the power of combining platforms in a joint analysis.
We believe this method can be applied to a variety of microarray data types.
However, further research is needed to validate the method on different types
of data such as ChIP–chip data.
A minor drawback of our method is that it does not allow for automated
selection of variables, but rather relies on pre-filtering the data. However,
most biologists are still relying on simple clustering algorithms such as K-
means or standard agglomerative algorithms, due to their simplicity in im-
plementation and interpretation. Thus, having a relatively simple and easily
implemented hierarchical algorithm that can integrate multiple platforms
and further utilizes the bimodal or skewed structure of the individual pro-
files, in a model-based manner, has its advantages. For example, the hi-
erarchical algorithm automatically determines the numbers of clusters and
provides an easily interpretable dendrogram. Also, as a side product, we
obtain posterior probabilities of high methylation/expression, E[wcj |y], for
each cluster c and probe set j. By ordering the probe sets with respect
to these posterior probabilities and excluding probe sets that are identical
across all clusters, we can explore patterns in heatmaps such as in Figure 2.
One of the novelties of our clustering algorithm is the inclusion of indi-
vidual specific parameters, (µ1i, σ
2
1i, µ2i, σ
2
2i)i, into the model of Section 3,
which facilitates the use of our algorithm even in the presence of extreme
microarray effects. Since the amount of data we have to estimate these pa-
rameters (G observations per subject) highly exceeds the number of sub-
jects (n), the estimation of these parameters has not been a problem. How-
ever, it is common practice to treat such individual specific parameters as
random effects. We have established that with conjugate normal and inverse
gamma priors on the above parameters we arrive at a marginal likelihood
intractable for maximization. However, we have verified that through such
prior specifications we could easily calculate full conditionals in a Bayesian
analysis. A Bayesian approach would also prevent us from having to as-
sume the methylation indicators, w, are fixed as in the iterative algorithm
of Section 4.2. The reason for that assumption was that the joint posterior
distribution of (w,X) is highly intractable. However, full conditionals for
each variable separately are easily obtained and are that of Bernoulli and
Multinomial, respectively. Running a fully Bayesian analysis might also fa-
cilitate an extended algorithm that could include all variables. One might
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assume that some variables are informative and follow the mixture in (6)
with prior probability p, whereas other variables are noninformative with
prior probability (1− p) and follow the mixture in (6) with C = [n]. There
are some challenges that arise in implementing such a fully Bayesian model
and those require further research.
Acknowledgments. The methods presented in this paper have been imple-
mented as an R-package that is available at http://www.stat.cornell.edu/
imac/.
SUPPLEMENTARY MATERIAL
Simulation and details of EM algorithms (DOI: 10.1214/11-AOAS533SUPP;
.pdf). We perform a simulation study to assess the performance of our clus-
tering algorithm in the presence of sparse correlation structure. We also
derive the steps involved in maximizing the likelihoods of the several models
presented in this paper.
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